A new platform to identify cardiotoxic drug molecules
Scitech Europa - 28-Jan-2019No need to wait till safety trials in humans to detect cardiotoxicity
Yimu Zhao
Scientist at Institute of Biomaterials and Biomedical Engineering, University of Toronto
Yimu Zhao is a 4th year Ph.D. Candidate in the laboratory of Dr. Milica Radisic at University of Toronto. Her Ph.D. thesis is to develop BiowireTM II drug testing platform (TC dish version and 96-well version) that is designed to 1) be minimally drug absorbable, 2) mature engineered cardiac tissues and 3) accurately evaluate inotropic and chronotropic responses of tissues with drugs. She is one of the inventors of TARA’s BiowireTM platform technology (Patent) and contributes significantly on tissue conditioning, maturation and drug screening optimization for platform development. She is one of the co-founders of TARA.
Details last updated 06-Feb-2020
Yimu Zhao News
